Literature DB >> 7100029

The clinical course of acute type A hepatitis in chronic HBsAg carriers--a report of 3 cases.

L A Viola, I G Barrison, J C Coleman, I M Murray-Lyon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7100029      PMCID： PMC2426311          DOI： 10.1136/pgmj.58.676.80

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Hepatitis B antigen and antibody in a male homosexual population.

Authors:  J C Coleman; M Waugh; R Dayton
Journal:  Br J Vener Dis       Date:  1977-04

2.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

3.  The occurrence of epidemic infectious hepatitis in chronic carriers of Australia antigen.

Authors:  D E Dietzman; E B Matthew; D L Madden; J L Sever; M Rostafinski; S M Bouton; B Nagler
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

4.  Hepatitis A in homosexuals.

Authors:  A Mindel; R Tedder
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-23

5.  Quantitative relationship between HBeAg and DNA polymerase activity in sera from patients with chronic active hepatitis during a three-month period.

Authors:  R A Heijtink; M van der Waart; W Weimar; S W Schalm; N Masurel
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

6.  Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.

Authors:  H B Greenberg; R B Pollard; L I Lutwick; P B Gregory; W S Robinson; T C Merigan
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

7.  Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness.

Authors:  S M Feinstone; A Z Kapikian; R H Purceli
Journal:  Science       Date:  1973-12-07       Impact factor: 47.728

8.  Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis.

Authors:  J W Mosley; A G Redeker; S M Feinstone; R H Purcell
Journal:  N Engl J Med       Date:  1977-01-13       Impact factor: 91.245

9.  De novo acute infection and reactivation of hepatitis B virus in established cirrhosis.

Authors:  A Theodossi; S P Wilkinson; B Portmann; Y White; A L Eddleston; R Williams; A J Zuckerman
Journal:  Br Med J       Date:  1979-10-13
  9 in total
  7 in total

1.  Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.

Authors:  I V Weller; A S Lok; A Mindel; P Karayiannis; S Galpin; J Monjardino; S Sherlock; H C Thomas
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

2.  Fulminant hepatitis A in chronic HBV carrier.

Authors:  J Y Wang; S D Lee; Y T Tsai; K J Lo; B N Chiang
Journal:  Dig Dis Sci       Date:  1986-01       Impact factor: 3.199

Review 3.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

4.  Acute delta superinfection in a previously unrecognised HBsAg carrier with transient loss of HBsAg simulating acute non-A, non-B hepatitis.

Authors:  C M Chu; Y F Liaw
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

5.  Dissociation of alanine aminotransferase values in acute hepatitis A patients with and without past experience to the hepatitis B virus.

Authors:  A A Papachristou; A S Dumas; V C Katsouyannopoulos
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

6.  Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection.

Authors:  K P Chin; S Govindarajan; A G Redeker
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

7.  Serological diagnosis of acute viral hepatitis.

Authors:  J H Hoofnagle; A Ponzetto; L R Mathiesen; J G Waggoner; Z B Bales; L B Seeff
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.